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Visual estimation is the most commonly used method to evaluate the degree of coronary artery stenosis 
prior to coronary artery bypass grafting. In interventional cardiology, the use of fractional flow reserve (FFR) 
to guide revascularization decisions has become routine. We investigated whether the preoperative FFR 
measurement of coronary lesions is associated with anastomosis graft function flow rate (functionality) 6 
months after surgical revascularization using a multiarterial grafting strategy. 
Methods and Results 
In this prospective double blind study, 67 patients were enrolled from two institutions In Europe and Canada. 
From these patients, 199 coronary lesions were assessed visually and with FFR at the time of the 
preoperative angiogram. Patients received coronary revascularization using multiple arterial grafts. A 
postoperative 6-month angiogram was performed to assess the functionality of the bypass grafts 
anastomoses. The primary outcome was the association between pre-operative FFR values and 
anastomotic graft functionality 6 months after surgery. 
Preoperative FFR was significantly associated with 6-months anastomotic flow ratefunction for all conduits 
and for all targets (p<0.001). An FFR value of ≤ 0.78 was associated with an anastomotic occlusion rate of 
3%.  
Conclusion 
We found a significant association between the preoperative FFR measurement of the target vessel and the 
6 months anastomosis functionality, with a cutoff of ≤ 0.78. Integration of FFR measurement into the pre-
operative diagnostic workup before multiarterial coronary surgical revascularization lead to improved 




The objective of surgical coronary revascularization is to restore blood supply to a myocardial territory that is 
ischemic or at risk of infarction through the interposition of a low-resistance conduit to the diseased coronary 
artery segment. The compliance of this bypass conduit must be sufficient to accommodate the high flow 
demands of systemic pressure with minimal pressure drop at the site of distal implantation [1]. 
Competitive flow occurs when the resistance of the coronary bypass graft closely matches that of the native 
coronary artery target [1, 2]. In this situation, both the native coronary artery and the bypass graft contribute 
to distal perfusion, each providing their own resistance to blood flow. For saphenous vein grafts, the 
pressures at the two ends of the circuit are identical, with only minor phasic variations, due to their large 
diameter and absence of muscular layers. In arterial grafts instead, due to the smaller diameter and higher 
vasomotor tone, the pressure at the proximal ostium is higher than at the distal anastomosis . Competitive 
flow between the native coronary artery and the arterial graft can result in further reductions of blood 
pressure through the conduit, which can cause the muscular layer to spasm and potentially close. This 
phenomenon has been widely reported in the literature [1, 3-5]. Given the near-universal use of the left 
internal thoracic artery (LITA) to graft the left anterior descending territory and the fact that current guidelines 
recommend the use of the right internal thoracic (RITA) and radial arteries (RA), the importance of the 
assessment of competitive flow should not be underestimated. 
Current methods to estimate the severity of the coronary stenosis and the potential for competitive flow 
include visual inspection [6], quantitative coronary angiography quantitative computerized angiography (QCA) [7] and fractional flow reserve (FFR) 
[8]. FFR is the only direct measurement method to assessof the hemodynamic effect of the a stenosis in terms of the reduction ofby measuring blood flow capacitypressure 
ratios in order to determine the ischemic potential of the stenosis. Several studies have shown that both 
visual inspection and QCA have poor correlation with FFR [9-13] and the 2018 European Guidelines for 
myocardial revascularization recommend that coronary artery lesions be measured with a FFR when 
evidence of ischemia is not available (Class I, Level of Evidence A) [14].  
FFR evaluation, however, has not been widely adopted during the diagnostic workup of patients referred for 
surgical revascularization and only limited evidence exists on the role of preoperative FFR in patients 
undergoing coronary artery bypass surgery (CABG)  
The Impact of Preoperative FFR on Arterial Bypass Graft flow rate (IMPAG) study was designed to evaluate 






We devised a prospective double-blind observational study performed in two different institutions in Belgium 
and Canada. The trial was registered (ClinicalTrials.gov Identifier: NCT02527044) and approved by the local 
research ethics boards in both institutions. All patients enrolled in the study provided written informed 
consent.   
Outcomes 
The primary outcome was the association between target vessel pre-operative FFR value and the 
anastomosis flow rate function at 6 months after surgery. Secondary outcome was the asssociation between 
target vessel pre-operative FFR value and anastomosis occlusion at 6 months after surgery.  
 
Study procedures 
Patients were eligible for the study if they had multi-vessel coronary artery disease and were referred for 
isolated CABG using multiple arterial grafts. Patients were excluded if they had previous cardiac surgery, or 
were not candidate for the use of multiple arterial bypass grafts. The full list of eligibility criteria can be found 
in Supplementary Table 1. Patients were enrolled at the time of the diagnostic angiogram, or at the time of 
the pre-operative consultation with a cardiac surgeon.   
Diagnostic angiography using either radial or femoral access was performed following the usual standard of 
care at each institution.  FFR measurements of all major disease vessels were performed using a 
PressureWire Certus Agile Tip (St. Jude MedicalAbbott St. Jude at Minneapolis, Minnesota, Plymouth, MN) 
with the use of intravenous adenosine as a hyperemic stimulus. FFR values were recorded by a study 
coordinator and blinded to the patient, interventional cardiologist, and surgeon.  
The sequence and strategy of arterial revascularization was left to the operating surgeon. After surgery, all 
patients received therapies as recommended by the current American College of Cardiology and American 
Heart Association guidelines, including smoking cessation counseling and the administration of antiplatelet 
agents, beta blockers, lipid medications, and angiotensin converting enzyme inhibitors [15, 16]. 
Patients underwent follow-up angiography of all bypass grafts and anastomoses six months after surgery. 
Nitroglycerin (2 mg) was injected into each graft before filming. At least, two orthogonal views of each 
internal thoracic or radial artery graft imaging were obtained, with continued exposure as required to 
visualize distal runoff and the size of the target coronary bed. Angiographic evaluations were performed by 2 
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observers (one interventional cardiologist and one cardiac surgeon) blinded to the pre-operative FFR values. 
In the case of disagreement between observers, a third observer (interventional cardiologist) decided the 
value. Following a described method [3], anastomotic graft functionality (flow rate) was scored as 0 for an 
occluded graft, 1 when the flow from the native coronary artery was dominant, 2 when flow supply from the 
native coronary and from the graft was balanced, and 3 when the native coronary was fully opacified by the 
graft. A graft was considered “non functional” for scores of 0 to 2 and “functional” for score of 3. The 
coronary run off was graded using a semi quantitative scale based on the importance of the coronary bed 
beyond the area of the stenosis (A: excellent runoff, B: moderate runoff and, C: poor runoff). 
Feasibility and Sample Size  
A pilot phase was conducted to assess feasibility and allow sample size calculation. Twenty patients were 
recruited, and all patients had a follow-up angiogram six months after CABG.  An average number of 3.8 
FFR measurements and arterial anastomoses per patients was observed with no loss to follow up. Patients 
of the pilot phase were included in the full trial. 
Sample size calculation was based on the results of the pilot phase and of a previously published trial [17]. 
We estimated a rate of 6-months graft failure of 5% in patients with positive FFR (>0.75) and 15% in patients 
with negative FFR (<0.75). With a power of 0.90 at an alpha level of 0.05, 414 anastomoses would be 
required to detect a statistically significant difference between groups. Assuming a 10% dropout rate, 
sample size was defined at 456 anastomoses. Based on the data of the pilot phase, 120 patients were 
deemed necessary. 
An interim efficacy analysis was pre-established at 50% of the sample size. Due to the high level of 
statistical significance of the interim analysis, the Steering Committee decided to describe the results of the 
trial in the present report. 
Analytic design and statistical analysis 
Continuous variables were reported as mean and standard deviation while categorical variables were 
reported as count and percentage.  The relationship between specific target FFR and degree of stenosis 
(DS) was investigated using linear regression and r2 was used to quantify the degree of correlation between 
the two variables. Receiver operating characteristic (ROC) curves was used to identify the FFR and DS cut-
off points with the highest discriminative power to predict non-functional anastomosis at 6-month 
angiography and the two variables were dichotomized accordingly. Areas under the ROC curves (AOC) was 
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used to compare the accuracy of FFR over the angiographic degree of stenosis (DS) to predict non-
functional anastomosis. If 95%CI AUC lower limit was <0.5 the variable was considered not predictive.  
Patient characteristics, graft configuration and target details including FFR and DS between functional and 
non-functional anastomoses were compared using t-test and chi-square test for continuous and categorical 
variable respectively. Variables associated with a P value <.20 were forced into mixed-effects longitudinal 
model with patient as the random effect to identify independent predictors of non-functional anastomoses. A 
stepwise selection based Akaike information criterion (AIC) was used to identify variables for the final model.  
The interaction between FFR and other target characteristics and graft configuration was further investigated 
using classification and regression trees method (CART).  
Statistical analyses were performed using SPSS version 22.0 (IBM, Armonk, NY) and R software, version 





Overall 64 of 68 patients underwent the planned 6-month angiographic control. Mean angiographic follow up 
was 6.6 months (SD 0.9). 
During the follow up period, 7 patients (10.2%) required 8 elective PCIs. Three patients had a RCA PCI due 
to distal RITA graft occlusion at a mean of 14.7 months post CABG. Three patients had a LAD PCI due to 
distal LITA occlusion at a mean of 7.3 months and one patient had a RCA and LAD PCI due to the occlusion 
of the RITA and the LITA after the sequential anastomosis at 5 months post CABG. There were no episodes 
of myocardial infarction or death. 
From 64 patients, 199 anastomoses from 150 grafts were evaluated. There were 36 patients with double 
sequential and 7 patients with triple sequential grafts. The Y graft configuration was used in 172 anastomoses 
(86.4%).  
The median percentage of DS was 70 (IQR:70-80) for LITA anastomoses, 80 (IQR:70-81.25) for RITA 
anastomoses and 82.5 (IQR:65-95) for RA anastomoses (P=0.01). Median FFR was 0.73 (IQR:0.67-0.80), 
0.71(IQR:0.65-0.75) for LITA anastomoses, 0.77 (IQR:0.69-0.82) for RITA anastomoses and 0.72 (IQR:0.64-
0.84) for RA anastomoses (P=0.001). 
Angiographic perfect patency rate was 85.2% for the LITA, 68.8% for the RITA and 76.7% for the RA 
anastomoses (P value for LITA vs RITA=0.052, LITA vs RA=0.38 and RITA vs RA=0.62). Forty-nine 
anastomoses were found to be non-functional (24%); of these, 27 (14%) were occluded, 13 (6%) presented a 
balanced flow and 9 presented reverse flow (4%). The proportion of functional anastomoses was 85.2% for 
the LITA, 68.8% for the RITA and 66.7% for the RA (P value for LITA vs RITA=0.01, LITA vs RA=0.16 and 
RITA vs RA=0.89). 
Among the 49 anastomoses found to be non-functional, the preoperative target vessel FFR was significantly 
lower for those who required PCI (n=8) vs those who did not (n=41) (median/IQR 0.80/0.76-0.81 vs 0.83/0.81-
0.89, P=0.01).Detailed description of the patients, the grafts and the anastomoses are given in Supplementary 
Tables 2-5. 
Primary endpoint analysis 
Preoperative FFR and angiographic DS presented a significant but very weak correlation (R2=3%, Figure 1). 
FFR but not DS were found predictive of non-functional anastomosis (FFR AUC 0.92; 95%CI 0.87-0.96 vs DS 
AUC 0.57, 95%CI 0.48-0.66; P value for comparison <0.001; Figure 2). FFR best cut off value was >0.78 with 
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a specificity of 0.78 and a sensitivity of 0.90 for non-functionality, while the DS best cut off value was <87.50 
with a specificity of 0.20 and a sensitivity of 0.92 for non-functionality.  
Table 1 compares patients, target and graft configuration between non-functional and functional anastomoses 
at 6-month angiogram. In non-functional anastomoses, the pre-operative FFR value was significantly higher 
than in functional anastomoses (0.83±0.07 vs 0.66±0.19; P<0.001; Figure 3A-overall, 3B-per target, 3C-per 
conduit and Figure 4), while DS distribution did not differ between the two groups (73±12 vs 76±14; P=0.12). 
Anastomosis to the circumflex artery and posterior descending artery were more likely to be non-functional 
(P=0.02). RITA and RA anastomosis were more likely to be non-functional when compared to LITA 
anastomosis (P=0.03). At multivariable analysis (Table 2), FFR <0.78 (OR 0.01; 95%CI 0-0.03; P<0.001) and 
diabetes (OR 0.29; 95%CI 0.09-0.77; P=0.02) were found to be associated with functional anastomosis while 
anastomosis to the posterior descending artery was associated with non-functional anastomosis (OR 5.09; 
95%CI 1.22-22.17; P=0.02). An FFR <0.70 was associated with zero probability of non-functional anastomosis 
while this probability increased sharply when FFR values increased to, and surpassed 0.70 (Figure 5).  
Recursive partitioning showed a non-functional anastomosis rate of 4% when FFR ≤ 0.78; 32% when FFR 
was between 0.79 and 0.83 and the target vessel was the circumflex artery; 80% when FFR was 0.79 to 0.83 
and the target was not the circumflex artery; and 87% when FFR was ≥0.83 (Figure 6).  
Secondary endpoint analysis  
FFR but not DS was found to be predictive of anastomosis occlusion (FFR AUC 0.86 95% CI: 0.78-0.93; vs 
DS AUC 0.59 95% CI: 0.49-0.70; P value for comparison <0.001; Supplementary Figure 1). FFR best cut off 
value was >0.78 with a specificity of 0.77 and a sensitivity of 0.92 for occlusion while the DS best cut off value 
was <87.50 with a specificity of 0.19 and a sensitivity of 0.92 for non-functionality.  
Supplementary Table 6 compares patient demographics, target and graft configuration between occluded and 
non-occluded anastomoses at 6-month angiography. FFR but not DS was found to be significantly higher in 
non-functional anastomoses (0.83±0.06 vs 0.68±0.18; P<0.001; Supplementary Figure 2A-overall, 2B-per 
target, 2C-per conduit) while DS distribution did not differ between the two groups (71±11 vs 75±14; P=0.11).  
At multivariable analysis (Supplementary Table 7), FFR <0.78 (OR 0.02; 95%CI 0-0.08; P<0.001) and use of 
the Y graft configuration (OR 0.20; 95CI 0.07-0.65; P=0.006) were associated with patent anastomosis. 
Recursive partitioning showed an occluded graft rate of 3% when FFR ≤0.78; 12% when FFR > 0.78 and the 
target was the circumflex artery and the number of sequential anastomosis was ≥ 2; 67% when FFR > 0.78 
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and target was other than circumflex artery; 86% when FFR ≥ 0.79 and target was the circumflex artery and 
the number of sequential anastomosis was < 2 (Supplementary Figure 3).  
Discussion 
We found a highly significant association between the preoperative FFR measurement and anastomotic flow 
rate function in arterial bypass grafts 6 months after surgery. The best FFR cut-off value was 0.78 with less 
than 2% of the anastomosis to target vessel with preoperative FFR below this cut-off found to be  non-
functional at the follow-up angiogram.  
The superiority of the arterial over venous graft is thought to result from favourable biological properties of 
the endothelium to protect this vessel against vasospasm, thrombus formation and atherosclerosis. In 2 
previous studies we have demonstrated that the resistance in venous graft appears negligible and therefore 
the pressure at the distal graft anastomosis is nearly equal to the aortic pressure, minimizing risk of 
competition flow [1- 3]. In contrary, arteries are more likely to have a higher pressure drop leading to more 
competition flow. 
FFR measurement has been validated as the most accurate invasive method of assessing the physiologic 
significance of a coronary artery stenosis [13]. This is reflected in studies such as the DEFER trial, which 
found that stenoses that were non-significant by FFR (≥ 0.75) were associated with a <1% risk of cardiac 
death or myocardial infarction whether or not they were stented [18]. Another key trial evaluating FFR was 
the FAME study, which found that FFR-guided PCI reduced the risk of death, repeat revascularization, and 
non-fatal myocardial infarction in the first year after the procedure [19]. Taken together, these prospective, 
randomized trials indicated clearly that FFR could identify lesions that warranted intervention, and that 
lesions that were not significant by FFR could safely be left alone.  As a result of these trials, the use of FFR 
is supported by the professional guidelines, and has been widely adopted by interventional cardiologists 
during PCI.  
However, FFR evaluation is not part of the standard assessment of CABG candidates and limited 
information on the role of FFR in cardiac surgery is available. Botman et al. examined the correlation 
between FFR measurement and graft patency, and found that grafting a stenosis with FFR>0.75 significantly 
increase the risk of graft occlusion (p<0.0001) [17].  Honda and colleagues evaluated the association 
between the preoperative FFR in the LAD and the intra-operative flow measured in the LITA-LAD graft and 
observed that FFR was positively correlated with graft flow, and systolic reverse flow [20].  The authors 
concluded that when a coronary lesion measured between 0.70 and 0.75 by FFR, there was a greater 
likelihood of competitive flow.  
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Fournier et al. performed a retrospective trial of 627 patients having at least one intermediate stenosis 
assessed as intermediate by either coronary angiography alone or angiography plus FFR [21]. The authors 
found that patients in the FFR-guided group had fewer anastomoses, and a lower rate of death and 
myocardial infarction 6 years after surgery (hazard ratio 0.59, 95% CI 0.38–0.93). 
Of note, the recent Fractional Flow Reserve Versus Angiography Randomization for Graft Optimization 
(FARGO) trial [22] found that FFR-guided CABG had similar graft failure rates and clinical outcomes as 
angiography-guided CABG. Reasons for the difference compared to our findings are probably likely the low 
power of the FARGO trial (the study was prematurely stopped at 58% of the planned enrolment and 
angiographic control was available in only 74% of the enrolled sample) and the prevalent (67%) use of vein 
grafts (much less sensitive to competitive flow than arterial grafts).A comparison between the two studei sis 
provided in Table 4. It is of note that in FARGO, there was a good correlation between the visual estimation 
of coronary artery stenosis and the FFR value, which contradict our findings and most of the published 
literature [23]. 
Currently at least two prospective randomized trials are evaluating the role of FFR in CABG. The GRAFFITI 
trial [24], is a prospective, randomized, double-blind, multi-centre study examining the rate of occluded 
bypass grafts one year after surgery between angiographic versus FFR guided CABG. The FFR-Guided 
Percutaneous Coronary Intervention and CABG Surgery in patients with multivessel CAD (FAME) 3 Trial is 
a prospective, multicentre, randomized study with MACCE at 1 year as the primary outcome, and enrolment 
is ongoing [25]. The results of these trials will help to define the role of FFR in improving the outcome of 
CABG patients. 
Our results suggest that preoperative FFR is associated with anastomotic arterial graft flow rate function at 
six months in CABG patients. Further studies are necessary to evaluate if the increase in angiographic 
functionality translates to improved clinical outcomes. 
Limitations 
The lack of a control group and the short follow-up are very important limitations. Even most importantly, this 
analysis was performed after inclusion of slightly more than 50% of the planned sample size so we cannot 
exclude that the study is underpowered and a type I error cannot be ruled out. However, the high level of 
significance for all the outcomes and the very narrow 95% CIs makes us confident in the solidity of our 
results. Also, the study was performed at two specialized care centres with expertise in performing both FFR 
and CABG with arterial grafts, and both the efficacy and safety results may not reflect the results in other 
centres and for surgeons using venous grafts. Finally, the study is obviously underpowered to detect 
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differences in clinical outcomes. 
Conclusion 
We describe a highly significant association between preoperative FFR and anastomotic arterial graft flow 
rate function at six months in CABG patients.  These results suggest that FFR may play an important role in 
pre-operative planning of coronary artery bypass grafting procedures, and should be utilized whenever 






Figure 1. Scatter plot between preoperative FFR and angiographic DS and linear regression line with 
95%CI.  
Figure 2. Receiver operating characteristic (ROC) curves to compare accuracy of FFR and DS in predicting 
non-functional anastomosis at 6-month angiography  
Figure 3. Sinaplot conveying information of both the number of data points, the density distribution, outliers 
of FFR value in non-functional vs functional anastomosis at 6 month-angiography.  
Figure 4. Distribution of preoperative FFR according to anastomosis functionality at 6-month angiography.   
Figure 5. Predicted probability of anastomosis non-functionality obtained from multivariable logistic model.  
Figure 6. Numbers in each box indicate proportion of non-functional grafts and percentage of anastomoses 
(on overall sample size) in each FFR category. 
Supplementary Figure 1. Receiver operating characteristic (ROC) curves to compare accuracy of FFR and 
DS in predicting occluded anastomosis at 6-month angiography  
Supplementary Figure 2. Sinaplot conveying information of both the number of data points, the density 
distribution, outliers of FFR value in occluded vs non-occluded anastomosis at 6 month-angiography.  
Supplementary Figure 3. Numbers in each box indicate proportion of occluded grafts and percentage of 
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(n = 49) 
Functional  
(n = 150) 
P value 
  Age   66.98 (10.98)   65.37 (10.35)    0.35  
  Dyslipidemia      37 (75.5)      120 (80.0)     0.64  
  Diabetes      13 (26.5)       63 (42.0)     0.07  
  Smoking      22 (44.9)       69 (46.0)     1.000  
  Renal insufficiency       4 ( 8.2)        4 ( 2.7)     0.20  
  Previous MI      11 (22.4)       40 (26.7)     0.69  
  LV Ejection fraction   64.92 (14.10)   62.03 (10.55)    0.12  
  Prior PCI      10 (20.4)       46 (30.7)     0.22  
  Angiographic stenosis   72.45 (11.73)   75.77 (13.66)    0.12  
  FFR    0.83 (0.07)    0.66 (0.19)   <0.001  
  Y graft      41 (83.7)      131 (87.3)     0.68  
  Target vessel              0.01  
     CX      23 (46.9)       54 (36.0)      
     DIA       2 ( 4.1)       20 (13.3)      
     LAD      10 (20.4)       53 (35.3)      
     PDA      14 (28.6)       23 (15.3)      
  Target vessel diameter    1.83 (0.37)    1.94 (1.93)    0.67  
  Conduit               0.02  
     LITA      12 (24.5)       69 (46.0)      
     RA       3 ( 6.1)        6 ( 4.0)      
     RITA      34 (69.4)       75 (50.0)      





Continuous data are 
presented as mean and 
(standard deviation). Categorical data as number and (percentage) 
Table 1. Patients and operative characteristics for non-functional vs functional anastomosis at 6 months 
follow-up. 
  
  Number of sequential 
anastomoses 
  1.41 (1.06)    1.01 (1.11)    0.03  
  SYNTAX score   21.12 (6.59)   22.93 (6.83)    0.10  
  Off pump surgery     43 (87.8)      115 (76.7)     0.14  
18 
 
  Odds 
Ratio 
95% CI P value Odds 
Ratio 
95% CI P value 
  Enter model Stepwise 
Diabetes  0.23 0.06-0.79 0.01 0.26 0.09-0.77 0.01 
        
LV EF  1.00 0.95-1.05 0.99    
DS>87.5%  0.51 0.07-3.82 0.51    
        
FFR<0.78  0.01 0.00-0.03 <0.0001 0.01 0.00-0.03 <0.0001 
N of 
sequentials 
 0.75 0.24-2.34 0.62    
Target CX Ref      
 DIA 2.72 0.08-93.10 0.57 1.38 0.11-16.88 0.80 
 LAD 6.31 0.30-132.62 0.23 3.80 0.86-16.81 0.07 
 PDA 4.69 1.02-21.55 0.04 5.09 1.22-21.17 0.02 
Conduit LITA Ref      
 RA 10.68 0.21-532.10 0.23    
 RITA 2.80 0.07-116.92 0.58    
Off pump  3.82 0.85-17.25 0.08 3.20 0.84-12.27 0.08 
SYNTAX 
score 
 0.97 0.89-1.06 0.51    
 
Table 2. Multivariable analysis for non-functional anastomosis at 6 month angiography. 
 
 
